← All diseases
Cancer
Hodgkin lymphoma
Would you like to receive a message when there is new research about Hodgkin lymphoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was investigated — and you receive a notification as soon as new research on Hodgkin lymphoma is published. View what Premium costs.
Publications and studies (1992)
- A Matching-Adjusted Indirect Comparison of PET-Guided BrECADD Versus PET-Guided ABVD, BEACOPP, and eBEACOPP in Advanced Hodgkin Lymphoma. (2026/07/23) ♡
- North-south disparity in cancer control progress in Italy: a joint analysis of incidence, mortality and survival time trends by geographical area. (2026/07/23) ♡
- Potential heterogeneity of epcoritamab associated adverse events in demographics and dosing regimens. (2026/07/23) ♡
- Tumoral immune microenvironment profiling in B-cell non-Hodgkin lymphoma stratifies patients in different prognostic groups. (2026/07/23) ♡
- CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma. (2026/07/22) ♡
- Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality. (2026/07/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Epidemiology of cancer in Khyber Pakhtunkhwa (KP), Pakistan, 2020-2023: a retrospective, province-wide, multicentre observational study. (2026/07/22) ♡
- Distinguishing EBV-positive classic Hodgkin lymphoma from EBV-positive DLBCL, NOS: diagnostic value and limits of immunohistochemical markers. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CircRNA-mediated regulation of immune checkpoints in lymphoma: a multidimensional network perspective. (2026/07/22) ♡
- Patient Perspectives on Non-Hodgkin Lymphoma: A Qualitative Study to Guide Selection of Clinical Trial Endpoints. (2026/07/17) ♡
- Pesticide exposure and all health outcomes: An umbrella review of meta-analyses of observational studies. (2026/07/16) ♡
- Geriatric Assessment in Patients Aged 70 Years and Older Considered for CAR T-Cell Therapy: A Retrospective Study. (2026/07/16) ♡
- Frontline ABVD Remains an Effective Option in Advanced-Stage Classical Hodgkin Lymphoma: Real-World Data from Turkey. (2026/07/16) ♡
- Adverse event reporting patterns of rituximab and obinutuzumab in B-cell non-Hodgkin lymphoma: a FAERS pharmacovigilance study. (2026/07/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Inflammasomes in Sjögren's Disease: Exploring the Therapeutic Value. (2026/07/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review. (2026/07/15) ♡
- The Danish Lymphoid Cancer Research (DALY-CARE): Genetic Cohort Profile. (2026/07/15) ♡
- The CD19-4-1BBL antibody fusion protein unleashes the immune system against high-risk chronic lymphocytic leukemia. (2026/07/15) ♡
- Proteomics and transcriptomics reveal molecular subtypes and biomarkers of advanced cutaneous T-cell lymphoma. (2026/07/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Clinical diagnosis and treatment of four cases of Castleman disease in children]. (2026/07/15) ♡
- Global welfare burden of hematologic malignancies from 2015 to 2023. (2026/07/14) ♡
- Genetically Predicted Gut Microbiota and Lymphoma Risk: A Mendelian Randomization Study. (2026/07/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. ALK-Negative Systemic Anaplastic Large Cell Lymphoma with Cutaneous Involvement Initially Mimicking Primary Cutaneous Disease: A Case Report. (2026/07/13) ♡
- A Parent-Delivered Foot Bath Intervention for Chemotherapy-Related Fatigue in Children with Cancer: A Family-Centered Randomized Controlled Trial. (2026/07/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Peptide-Drug Conjugates for Targeted Delivery in Hematological Malignancies: From Design Principles to Clinical Application. (2026/07/13) ♡
- C-POEM as a therapeutic approach for cricopharyngeal achalasia. (2026/07/13) ♡
- Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma. (2026/07/10) ♡
- A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen. (2026/07/10) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy-safety trade-off and patient selection: a meta-analysis informing clinical choice between CAR-T and bispecific antibodies for R/R B-NHL. (2026/07/09) ♡
- Prophylactic PEG-rhG-CSF Reduces Febrile Neutropenia in Pediatric Hematological Malignancies Compared with Daily rhG-CSF. (2026/07/09) ♡
- Long-term outcomes of haploidentical hematopoietic stem cell transplantation with antithymocyte globulin-based myeloablative conditioning in pediatric refractory or relapsed non-Hodgkin lymphoma. (2026/07/08) ♡
- From Cure to Combat: Deployment After Lymphoma. (2026/07/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG PET/CT) in the Characterization of Massive Cardiac Infiltration by Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS). (2026/07/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Adrenals Under Silent Siege: Diffuse Large B-Cell Lymphoma Presenting as Addisonian Crisis. (2026/07/07) ♡
- Sufficient-dose Brentuximab vedotin improves prognosis in patients with classic Hodgkin lymphoma: a single-center real-world study in China. (2026/07/06) ♡
- Glasgow Prognostic Score and Gustave Roussy Immune Score in Hodgkin Lymphoma: Survival Associations and Limited Incremental Prognostic Value Beyond the International Prognostic Score. (2026/07/02) ♡
- Hierarchical vision transformers for Epstein-Barr virus status and histological subtype prediction in Hodgkin lymphoma whole-slide images. (2026/07/02) ♡
- Autologous Stem Cell Transplantation Of HIV-Positive Plasmablastic Lymphoma - Case Series. (2026/07/01) ♡
- Clinicopathological Characteristics and Expressor Patterns of C-MYC and EBV in Large B Cell Lymphoma. (2026/07/01) ♡
- Long-Term Treatment Outcomes in Patients with Hodgkin Lymphoma Treated with Conventional Therapy. (2026/07/01) ♡
- Immunohistochemical Detection of Galectin-1 in Classical Hodgkin Lymphoma and its Correlation with Epstein-Barr Virus LMP-1 Expression and Other Clinicopathological Features. (2026/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A Case of B-lymphoblastic Lymphoma with MYC Rearrangement Mimicking Burkitt Lymphoma. (2026/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Aggressive Primary Sacral Non-Hodgkin Lymphoma Associated With Systemic Lupus Erythematosus. (2026/07/01) ♡
- Mental Distress, Fatigue and Executive Function in Adult Survivors of Childhood Leukemia and Non-Hodgkin Lymphoma. (2026/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Avascular Necrosis of the Femoral Head after Hodgkin Lymphoma Treatment: Analysis of Risk Factors and Mid-Term Outcomes after Total Hip Replacement]. (2026/07/01) ♡
- Cancer Burden in Bangladesh: Age- and Sex-Specific Incidence, Prevalence, Mortality, and Forecasts Up to 2050. (2026/07/01) ♡
- Cancer Distribution Pattern in the City of Kenitra, Morocco (2017-2022): A Pathology-Based Study. (2026/07/01) ♡
- Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers. (2026/07/01) ♡
- Functional immune profiling reveals CD4(+) T cell dysregulation in coeliac disease. (2026/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. When "Metastatic Disease" Is Not Metastatic: Diffuse Large B-cell Lymphoma Presenting With a Perisplenic Mass, Pulmonary Masses, Pleural Effusion, and Retroperitoneal Lymphadenopathy. (2026/06/30) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.